Covered recipient · General Payments record
KRISTEN B OSTERRIEDER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$8,506.77
- Reported across 382 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $470.45 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $168.75 | 4 |
| Novo Nordisk AS | $114.00 | 5 |
| Xeris Pharmaceuticals, Inc. | $88.95 | 5 |
| Radius Health, Inc. | $48.20 | 2 |
| Medtronic, Inc. | $34.61 | 1 |
| Amgen Inc. | $15.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.94 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117344632 | CMS |
| Lilly USA, LLC | $21.12 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135761761 | CMS |
| Lilly USA, LLC | $16.24 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135783924 | CMS |
| Lilly USA, LLC | $18.15 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135774974 | CMS |
| Lilly USA, LLC | $113.24 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135781244 | CMS |
| Medtronic, Inc. | $34.61 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116921280 | CMS |
| Novo Nordisk Inc | $23.12 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100550842 | CMS |
| Novo Nordisk Inc | $23.12 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100428905 | CMS |
| Novo Nordisk Inc | $18.28 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100270315 | CMS |
| Novo Nordisk Inc | $23.88 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100328374 | CMS |
| Novo Nordisk Inc | $25.60 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100409161 | CMS |
| Radius Health, Inc. | $28.84 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090027585 | CMS |
| Radius Health, Inc. | $19.36 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090027593 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.86 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144631987 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.28 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144631989 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.28 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144631993 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.56 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144631991 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.97 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144631995 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.